1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet . 2015;386(10003):1546-1555.
2. Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B--United States, 1974-2008. PLoS One. 2011;6(12):e27717.
3. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology . 2012;56(2):422-433.
4. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18(6):377-383.
5. Hutton DW, Tan D, So SK, Brandeau ML. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007;147(7):460-469.
6. Eckman MH, Kaiser TE, Sherman KE. The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis . 2011;52(11):1294-1306.
7. Weinbaum CM, Williams I, Mast EE, et al; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep . 2008;57(RR-8):1-20.
8. LeFevre ML; U.S. Preventive Services Task Force. Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med . 2014;161(1):58-66.
9. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology . 2009;50(3):661-662.
10. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology . 2016;63(1):261-283.
11. Centers for Disease Control and Prevention (CDC). Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005. MMWR Morb Mortal Wkly Rep . 2006;55(18):505-509.
12. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology . 2007;46(4):1034-1040.
13. Lai CJ, Nguyen TT, Hwang J, Stewart SL, Kwan A, McPhee SJ. Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ . 2007;22(1):37-41.
14. Colvin HM, Mitchell AE, eds; Committee on the Prevention and Control of Viral Hepatitis Infections Board on Population Health and Public Health Practice. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C . Washington, DC: National Academies Press; 2010:xix, 232.
15. Hepatitis B Fact Sheet No. 204. World Health Organization Website. http://www.who.int/entity/mediacentre/factsheets/fs204/en/. Updated July 2015. Accessed March 17, 2016.
16. Perz JF, Openo K, Ahmed F, Bell BP. P.382 Trends in mortality from liver cancer in the USA, 1993-2002. J Clin Virol . 2006;36(suppl 2):S178.
17. Chang ET, Keegan TH, Gomez SL, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer . 2007;109(10):2100-2108.
18. Fattovich G1, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol . 2008;48(2):335-352.
19. Chou R, Dana T, Bougatsos C, Blazina I, Khangura J, Zakher B. Screening for hepatitis B virus infection in adolescents and adults: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med . 2014;161(1):31-45.
20. Wan KJ, Miyoshi T, Fryer G, et al. Screening for hepatitis B virus infection by primary care physicians in New York City: are screening recommendations for persons born inendemic countries being followed?[abstract 1454]. Hepatology . 2007;46(suppl):889A-890A.
21. Thompson MJ, Taylor VM, Jackson JC, et al. Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ . 2002;17(4):222-226.
22. Ma GX, Fang CY, Shive SE, Toubbeh J, Tan Y, Siu P. Risk perceptions and barriers to hepatitis B screening and vaccination among Vietnamese immigrants. J Immigr Minor Health . 2007;9(3):213-220.
23. Taylor VM, Choe JH, Yasui Y, Li Lin, Burke N, Jackson JC. Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. J Community Health . 2005;30(6):477-490.
24. Weinbaum CM, Lyerla R, Mackellar DA, et al; Young Men’s Survey Study Group. The young men’s survey phase II: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health . 2008;98(5):839-845.
25. Marcellin P, Gane E, Buti M. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet . 2013;381(9865):468-475.
26. Chang TT, Liaw YF, Wu SS. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology . 2010;52(3):886-893.
27. Wong GL, Chan HL, Mak CW. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology .2013;58(5):1537-1547.
